State Street’s TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK TRIV Stock Holding History
Bought
Maintained
Sold
Other funds holding TRIV
NMC
MAM
RG
USAA
BCM
State Street's TRIV Position: Q2 2015 in Review
State Street sold out of TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK (TRIV) in Q2 2015, closing a stake of 67,975 shares — an estimated $711K sold.
State Street first reported a position in TRIV in Q2 2014 and held it in 4 quarters. The position peaked at $761K in Q4 2014. 36 funds tracked by Wall St. Rank hold TRIV as of Q2 2015.
- State Street reported no remaining TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK position as of Q2 2015 after selling out during the quarter.
- State Street sold 67,975 TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK shares in Q2 2015, an estimated $711K.
- State Street first reported a position in TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK in Q2 2014 and held it in 4 quarters.
- State Street's TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK position peaked at $761K in Q4 2014.
- 36 funds tracked by Wall St. Rank held TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK as of Q2 2015.
Based on State Street's 13F filing for Q2 2015, filed 13 Aug 2015.